Emergent BioSolutions Inc (STU:ER4)
€ 3.836 +0.018 (+0.47%) Market Cap: 197.62 Mil Enterprise Value: 580.52 Mil PE Ratio: 0 PB Ratio: 0.67 GF Score: 67/100

Emergent BioSolutions Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 01:15 AM GMT
Release Date Price: €9.39 (-12.22%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EBS.N - Emergent BioSolutions Inc
Emergent BioSolutions Inc at JPMorgan Healthcare Conference
Jan 15, 2026 / 01:15AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great. Welcome everyone. My name is Jessfai. I'm a biotech analyst at JPMorgan and we're continuing our forty-fourth annual healthcare conference today with Emergent. First, you're going to hear a presentation from the company and then we're going to have some Q&A. So for those of you in the room, if you want to ask a question, just raise your hands, and someone will bring you a microphone for the webcast and alternatively, for those listening online, you can submit questions, via the portal and I can read them off the iPad up here. So with that out of the way, let me pass it over to Emergent CEO Joe Papa.

--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot